Organization
Northwestern University Feinberg School of Medicine, Chicago, IL
3 abstracts
Abstract
Phase 1 study of BDTX-1535, an oral 4th generation covalent EGFR inhibitor, in patients with recurrent glioblastoma: Preliminary dose escalation results.Org: Division of Neuro-Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA, Tennessee Oncology, PLLC, Sarah Cannon Research Institute, Nashville, TN, Sarah Cannon Research Institute at HealthONE, Denver, CO, NEXT Oncology Virginia, Fairfax, VA,
Abstract
The impact of the 4R Oncology model of team-based care delivery on timing and sequence of guideline recommended interdependent care in breast and lung cancers.Org: Center for Business Models on Healthcare, Glencoe, IL, Genentech Inc, South San Francisco, CA, Albert Einstein College of Medicine, Bronx, NY, Northwestern University Feinberg School of Medicine, Chicago, IL,
Abstract
“IS THIS REALLY THE WAY WE SHOULD GO?” – PATIENT PERSPECTIVES ON RHEUMATOID ARTHRITIS MANAGEMENT Org: Orthopedics, University of Massachusetts Medical School, Meyers Primary Care Institute, Worcester, Albany Medical College, Albany, Global Healthy Living Foundation, Upper Nyack, Johns Hopkins University, Baltimore, MD,